Upcoming Events

43rd International Conference on Screening for Lung Cancer and 11th Conference on Research for Early Lung Cancer Treatment

Wednesday, September 21, 2022 to Friday, September 23, 2022
New York, New York
United States

The mission of our conference is to explore and address the issues surrounding early diagnosis of lung cancer, how to optimize early treatment, and to expand practice-relevant research to medical and scientific communities in the U.S. and abroad. This is the 43rd conference in a series of conferences that began in 1999 in New York City and, since, has been hosted in China, Europe, Israel, Japan, and coast-to-coast in the United States.

The Early Lung Cancer Action Program (ELCAP) screening effort began in 1992 and evolved into the International Early Lung Cancer Action Program (I-ELCAP). By providing training and the ELCAP Management System to those interested in screening, these programs expanded worldwide. The resulting data and analyses provide new diagnostic knowledge that is being continually integrated into the screening regimen so that it remains state-of-the-art. The screening advances are addressed at every conference. In addition, the Early Lung Cancer Research on Treatment (IELCART) uses the power of the prospective cohort design to accumulate data on treatment delivered for Stage I lung cancer and to address questions about optimal treatment. The IELCART research goal is to maximize the benefit of screening by determining optimal treatment for these Stage I lung cancer patients.

Conference Registration

We hope you will be able to join us for our first in-person conference in two years! The conference takes place at two venues: the Hotel Beacon on the first day, September 21, 2022, and Mount Sinai Morningside Hospital on the 2nd and 3rd days, September 22-23, 2022. For those not able to attend in-person, we will be livestreaming the entire conference using Zoom. There is NO FEE for attending either in person or virtually.

To register for the conference, please proceed to the registration page. Feel free to pass on this registration link to any of your colleagues/students/fellows/residents who may be interested in attending.

Upon registering, you will be provided a single link that you can use to attend virtually for all three days of the conference. This link is unique to you; please do not share your link. (However, feel free to share the registration link.) If you are attending in person, please note the venue changes for each day of the conference.

Should you have any questions, or problems with registration, you can contact the Conference Coordinator, Maryanne Rubacky at maryanne.rubacky@mountsinai.org

COVID Requirements for In-person Attendance at Mount Sinai Morningside Hospital

Currently Mount Sinai requires masking and proof of COVID-19 vaccination for admittance to any Mount Sinai facility. Please bring proof of vaccination to show Security.



REGISTER HERE


Agenda

The agenda for 43rd International Conference on Screening for Lung Cancer and 11th Conference on Research for Early Lung Cancer Treatment is now available! Download the agenda here.

Date: 
Wednesday, September 21, 2022
Venue: 
Hotel Beacon NYC
Between 74th and 75th Streets 2130 Broadway
New York, NY 10023
United States
Date: 
Thursday, September 22, 2022
Venue: 
Mount Sinai Morningside Hospital
Conference Center P4 440 W 114th St
New York, NY 10025
United States
Date: 
Friday, September 23, 2022
Venue: 
Mount Sinai Morningside Hospital
Conference Center P4 440 W 114th St
New York, NY 10025
United States